Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,884 | -7,378 | -43,561 | -36,876 | -28,205 |
| Depreciation Amortization | 586 | 328 | 1,272 | 966 | 678 |
| Accounts receivable | -3,400 | -1,502 | -3,399 | 36 | 36 |
| Accounts payable and accrued liabilities | 205 | 395 | -1,236 | -733 | -1,095 |
| Other Working Capital | -6,427 | -6,716 | -19,267 | -16,223 | -12,325 |
| Other Operating Activity | 8,362 | 3,471 | 14,717 | 8,573 | 6,642 |
| Operating Cash Flow | $-15,558 | $-11,402 | $-51,474 | $-44,257 | $-34,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,464 | 12,589 | 30,750 | 12,750 | 3,000 |
| PPE Investments | -442 | -351 | -307 | -335 | -337 |
| Purchase Of Investment | -6,892 | 0 | -42,524 | -42,524 | -41,040 |
| Investing Cash Flow | $12,130 | $12,238 | $-12,081 | $-30,109 | $-38,377 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -19,040 | -1,667 | -1,667 | N/A | N/A |
| Common Stock Issued | 29 | 25 | 61 | 61 | 48 |
| Financing Cash Flow | $-19,011 | $-1,642 | $-1,606 | $61 | $48 |
| Beginning Cash Position | 43,350 | 43,350 | 108,511 | 108,511 | 108,511 |
| End Cash Position | 20,911 | 42,544 | 43,350 | 34,206 | 35,913 |
| Net Cash Flow | $-22,439 | $-806 | $-65,161 | $-74,305 | $-72,598 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,558 | -11,402 | -51,474 | -44,257 | -34,269 |
| Capital Expenditure | -490 | -351 | -537 | -512 | -506 |
| Free Cash Flow | -16,048 | -11,753 | -52,011 | -44,769 | -34,775 |